<p>The <i>vertical axis</i> at 1.89 indicates the overall HR, and the <i>two vertical axes</i> at 1.38 and 2.60 indicate the 95% CI. Every <i>hollow round</i> indicates the pooled HR when the left study was omitted in a meta-analysis with a random model. The <i>two ends</i> of every <i>broken line</i> represent the respective 95% CI.</p
The key goal of metabolomic studies is to identify relevant individual biomarkers or composite metab...
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
<p>(A) Representative PRM overlays show stable disease (top) and progressive disease (bottom) for PR...
<p>All pooled <i>HR</i><b><i>s</i></b> were derived from random-effect model.</p><p><i>P</i><sub>h</...
<p>All pooled <i>OR</i><b><i>s</i></b> were derived from random-effect model except for cells marked...
<p>The middle vertical axis represents the pooled HR and the 2 vertical axes indicate the correspond...
<p>Each square denotes the HR for that trial comparison with the horizontal lines showing the 95% CI...
<p>Each square denotes the HR for that trial comparison with the horizontal lines showing the 95% CI...
<p>p53-AAbs: p53 autoantibodies; FIGO: International Federation of Gynaecology and Obstetrics; PLT: ...
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
*<p>HRs and 95%CIs in the random-effect model are: 1.29(0.97, 1.71), 1.33(0.94, 1.9), 1.85(1.12, 3.0...
<p>This figure shows the influence of individual studies on the summary OR. The middle vertical axis...
<p>PCC values and accompanying <i>c</i>-values are displayed for individuals and pooled groups. Ten ...
*<p>One study did not provide the data for the number of patients and controls <a href="http://www.p...
The key goal of metabolomic studies is to identify relevant individual biomarkers or composite metab...
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
<p>(A) Representative PRM overlays show stable disease (top) and progressive disease (bottom) for PR...
<p>All pooled <i>HR</i><b><i>s</i></b> were derived from random-effect model.</p><p><i>P</i><sub>h</...
<p>All pooled <i>OR</i><b><i>s</i></b> were derived from random-effect model except for cells marked...
<p>The middle vertical axis represents the pooled HR and the 2 vertical axes indicate the correspond...
<p>Each square denotes the HR for that trial comparison with the horizontal lines showing the 95% CI...
<p>Each square denotes the HR for that trial comparison with the horizontal lines showing the 95% CI...
<p>p53-AAbs: p53 autoantibodies; FIGO: International Federation of Gynaecology and Obstetrics; PLT: ...
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
*<p>HRs and 95%CIs in the random-effect model are: 1.29(0.97, 1.71), 1.33(0.94, 1.9), 1.85(1.12, 3.0...
<p>This figure shows the influence of individual studies on the summary OR. The middle vertical axis...
<p>PCC values and accompanying <i>c</i>-values are displayed for individuals and pooled groups. Ten ...
*<p>One study did not provide the data for the number of patients and controls <a href="http://www.p...
The key goal of metabolomic studies is to identify relevant individual biomarkers or composite metab...
<p>Data were obtained in 74 healthy subjects, who underwent 24-h blood sampling at 10-min intervals....
<p>(A) Representative PRM overlays show stable disease (top) and progressive disease (bottom) for PR...